Not known Details About modafinil
Belzutifan is usually a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors may boost incidence or severity of adverse effects. Check for anemia and hypoxia and decrease belzutifan dose as advisable.elvitegravir/cobicistat/emtricitabine/tenofovir DF will increase levels of modafinil by influencing hepatic/intestinal enzyme CYP3A4 metabolism